Dashboard
Manage Tickers

CCChemours Co

NYSE chemours.com


$ 28.18 $ 0.52 (1.88 %)    

Thursday, 09-May-2024 15:22:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.90 $ 0.44 (0.1 %)
DIA $ 393.79 $ 3.38 (0.87 %)
SPY $ 519.62 $ 2.18 (0.42 %)
TLT $ 90.66 $ 0.62 (0.69 %)
GLD $ 216.17 $ 1.47 (0.68 %)
$ 27.5
$ 27.66
$ 28.15 x 200
$ 0.00 x 0
$ 27.39 - $ 28.20
$ 15.10 - $ 38.06
1,077,014
na
4.09B
$ 1.90
nm
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 10-27-2023 09-30-2023 10-Q
4 07-28-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-29-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-11-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-14-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-15-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chemours-discontinues-us-sales-of-legacy-freon-refrigerants-404a-and-507
Chemours Discontinues US Sales Of Legacy F...
05/02/2024 10:49:45

Chemours will discontinue U.S. sales of these select Freon products as of May 2, 2024, in support of regulatory phasedown requi...

chemours-expects-q2-consolidated-net-sales-to-increase-approximately-15-sequentially
Chemours Expects Q2 Consolidated Net Sales...
04/30/2024 20:52:07

Consolidated Adjusted EBITDA also to be up approximately 15% compared with first quarter 2024 results.

chemours-q1-2024-adj-eps-032-beats-018-estimate
Chemours Q1 2024 Adj EPS $0.32 Beats $0.18...
04/30/2024 20:31:31

Chemours (NYSE:CC) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.18 by 77.78 p...

chemours-q1-sales-1350b-beat-1349b-estimate
Chemours Q1 Sales $1.350B Beat $1.349B Est...
04/30/2024 20:29:56

Chemours (NYSE:CC) reported quarterly sales of $1.350 billion which beat the analyst consensus estimate of $1.349 billion by 0....

wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
04/16/2024 11:48:10

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

why-chemours-gets-a-double-upgrade-from-this-analyst
Why Chemours Gets A Double Upgrade From Th...
04/09/2024 16:56:56

Chemours Co (NYSE: CC) reported in late March its fourth-quarter earnings ahead of expectations.

bmo-capital-upgrades-chemours-to-outperform-raises-price-target-to-34
BMO Capital Upgrades Chemours to Outperfor...
04/09/2024 09:48:08

BMO Capital analyst John McNulty upgrades Chemours (NYSE:CC) from Market Perform to Outperform and raises the price target f...

peering-into-chemourss-recent-short-interest
Peering Into Chemours's Recent Short Interest
04/04/2024 13:00:21

ubs-maintains-neutral-on-chemours-raises-price-target-to-28
UBS Maintains Neutral on Chemours, Raises ...
04/02/2024 20:07:07

UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Neutral and raises the price target from $21 to $28.

peeling-back-the-layers-exploring-chemours-through-analyst-insights
Peeling Back The Layers: Exploring Chemour...
04/02/2024 20:01:16

barclays-maintains-equal-weight-on-chemours-lowers-price-target-to-30
Barclays Maintains Equal-Weight on Chemour...
04/02/2024 18:13:28

Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $32 to $30.

micron-iris-energy-tripcom-group-and-other-big-stocks-moving-higher-on-monday
Micron, Iris Energy, Trip.com Group And Ot...
04/01/2024 17:02:28

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.

why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Kodiak Sciences Shares Are Trading Low...
03/28/2024 18:08:52

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

why-rh-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket
Why RH Shares Are Trading Higher By Around...
03/28/2024 12:21:31

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

why-chemical-company-chemours-shares-are-plunging-premarket-today
Why Chemical Company Chemours Shares Are P...
03/28/2024 12:16:19

Chemours shares fall as internal review reveals delayed payments and lack of transparency in management.

wall-street-eyes-muted-open-as-caution-prevails-before-key-inflation-data-analyst-sees-buying-opportunities-in-any-pullback
Wall Street Eyes Muted Open As Caution Pre...
03/28/2024 11:41:52

Following Wednesday’s late surge that pushed the S&P 500 Index to a record high, the market sentiment has shifted to cautious.

millerknoll-posts-weak-sales-joins-chemours-rumble-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
MillerKnoll Posts Weak Sales, Joins Chemou...
03/28/2024 09:25:01

U.S. stock futures were mixed this morning, with the Dow futures gaining by around 10 points on Thursday.

chemours-expects-q1-consolidated-net-sales-to-be-flat-to-slightly-down-sequentially
Chemours Expects Q1 Consolidated Net Sales...
03/27/2024 21:39:47

The Company expects an approximate 10% sequential decline in TT Net Sales for first quarter 2024 due to weaker demand for TiO2....

chemours-discloses-material-weaknesses-and-remediation-plan
Chemours Discloses Material Weaknesses And...
03/27/2024 21:36:49

As disclosed in the Company's Annual Report on Form 10-K filed today, March 27, 2024, the Audit Committee of the Board of D...

chemours-q4-adj-eps-031-beats-025-estimate-sales-136b-beat-132b-estimate
Chemours Q4 Adj EPS $0.31 Beats $0.25 Esti...
03/27/2024 21:33:22

Chemours (NYSE:CC) reported quarterly Adj earnings of $0.31 per share which beat the analyst consensus estimate of $0.25 by 24 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION